Carbamazepine Enhances Adipogenesis by Inhibiting Wnt/β-Catenin Expression

Carbamazepine is a drug that is widely used in the treatment of epilepsy and bipolar disorder. The prevalence of obesity in patients treated with carbamazepine has been frequently reported. However, whether carbamazepine affects adipogenesis, one of the critical steps in the development of obesity,...

Full description

Bibliographic Details
Main Authors: Dong Uk Im, Sang Chon Kim, Gia Cac Chau, Sung Hee Um
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/8/11/1460
_version_ 1797761284506124288
author Dong Uk Im
Sang Chon Kim
Gia Cac Chau
Sung Hee Um
author_facet Dong Uk Im
Sang Chon Kim
Gia Cac Chau
Sung Hee Um
author_sort Dong Uk Im
collection DOAJ
description Carbamazepine is a drug that is widely used in the treatment of epilepsy and bipolar disorder. The prevalence of obesity in patients treated with carbamazepine has been frequently reported. However, whether carbamazepine affects adipogenesis, one of the critical steps in the development of obesity, remains unclear. Here, we show that carbamazepine increased the expression levels of peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer-binding protein β (C/EBPβ), and fatty acid synthase (FASN) in 3T3-L1 cells. Notably, carbamazepine inhibited the expression levels of β-catenin, a negative regulator of adipogenesis, leading to enhanced adipogenesis. Conversely, β-catenin overexpression abolished the effect of carbamazepine on adipogenic gene expression. However, depletion of β-catenin further enhanced PPARγ expression. In addition, carbamazepine reduced β-catenin expression by lowering the levels of phospho-low density lipoprotein receptor-related protein 6 (p-LRP6) and phospho-glycogen synthase kinase 3β (p-GSK3β) in Wnt/β-catenin signaling. Moreover, carbamazepine reduced Wnt mRNA expression and decreased the promoter activities of TCF, the target of β-catenin during adipogenesis. These results suggest that carbamazepine enhances adipogenesis by suppressing Wnt/β-catenin expression, indicating its potential effects on obesity-related metabolism.
first_indexed 2024-03-12T19:10:44Z
format Article
id doaj.art-0c58fd032c4f439193b34b11dd9f0441
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T19:10:44Z
publishDate 2019-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-0c58fd032c4f439193b34b11dd9f04412023-08-02T05:52:10ZengMDPI AGCells2073-44092019-11-01811146010.3390/cells8111460cells8111460Carbamazepine Enhances Adipogenesis by Inhibiting Wnt/β-Catenin ExpressionDong Uk Im0Sang Chon Kim1Gia Cac Chau2Sung Hee Um3Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Gyeonggi-do 16419, KoreaDepartment of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Samsung Medical Center, Sungkyunkwan University, Seoul 06351, KoreaDepartment of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Gyeonggi-do 16419, KoreaDepartment of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Gyeonggi-do 16419, KoreaCarbamazepine is a drug that is widely used in the treatment of epilepsy and bipolar disorder. The prevalence of obesity in patients treated with carbamazepine has been frequently reported. However, whether carbamazepine affects adipogenesis, one of the critical steps in the development of obesity, remains unclear. Here, we show that carbamazepine increased the expression levels of peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer-binding protein β (C/EBPβ), and fatty acid synthase (FASN) in 3T3-L1 cells. Notably, carbamazepine inhibited the expression levels of β-catenin, a negative regulator of adipogenesis, leading to enhanced adipogenesis. Conversely, β-catenin overexpression abolished the effect of carbamazepine on adipogenic gene expression. However, depletion of β-catenin further enhanced PPARγ expression. In addition, carbamazepine reduced β-catenin expression by lowering the levels of phospho-low density lipoprotein receptor-related protein 6 (p-LRP6) and phospho-glycogen synthase kinase 3β (p-GSK3β) in Wnt/β-catenin signaling. Moreover, carbamazepine reduced Wnt mRNA expression and decreased the promoter activities of TCF, the target of β-catenin during adipogenesis. These results suggest that carbamazepine enhances adipogenesis by suppressing Wnt/β-catenin expression, indicating its potential effects on obesity-related metabolism.https://www.mdpi.com/2073-4409/8/11/1460carbamazepineobesityadipocyte differentiationadipogenesiswnt/β-catenin
spellingShingle Dong Uk Im
Sang Chon Kim
Gia Cac Chau
Sung Hee Um
Carbamazepine Enhances Adipogenesis by Inhibiting Wnt/β-Catenin Expression
Cells
carbamazepine
obesity
adipocyte differentiation
adipogenesis
wnt/β-catenin
title Carbamazepine Enhances Adipogenesis by Inhibiting Wnt/β-Catenin Expression
title_full Carbamazepine Enhances Adipogenesis by Inhibiting Wnt/β-Catenin Expression
title_fullStr Carbamazepine Enhances Adipogenesis by Inhibiting Wnt/β-Catenin Expression
title_full_unstemmed Carbamazepine Enhances Adipogenesis by Inhibiting Wnt/β-Catenin Expression
title_short Carbamazepine Enhances Adipogenesis by Inhibiting Wnt/β-Catenin Expression
title_sort carbamazepine enhances adipogenesis by inhibiting wnt β catenin expression
topic carbamazepine
obesity
adipocyte differentiation
adipogenesis
wnt/β-catenin
url https://www.mdpi.com/2073-4409/8/11/1460
work_keys_str_mv AT dongukim carbamazepineenhancesadipogenesisbyinhibitingwntbcateninexpression
AT sangchonkim carbamazepineenhancesadipogenesisbyinhibitingwntbcateninexpression
AT giacacchau carbamazepineenhancesadipogenesisbyinhibitingwntbcateninexpression
AT sungheeum carbamazepineenhancesadipogenesisbyinhibitingwntbcateninexpression